Cargando…
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors
Chemotherapy remains one of the main treatment modalities for cancer. While chemotherapy is mainly known for its ability to kill tumor cells directly, accumulating evidence indicates that it also acts indirectly by enhancing T cell-mediated anti-tumor immunity sometimes through immunogenic cell deat...
Autores principales: | Vorontsova, Avital, Cooper, Tim J., Haj-Shomaly, Jozafina, Benguigui, Madeleine, Levin, Sapir, Manobla, Bar, Menachem, Rotem, Timaner, Michael, Raviv, Ziv, Shaked, Yuval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984299/ https://www.ncbi.nlm.nih.gov/pubmed/36646904 http://dx.doi.org/10.1038/s41388-023-02590-0 |
Ejemplares similares
-
Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors
por: Benguigui, Madeleine, et al.
Publicado: (2022) -
T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
por: Haj-Shomaly, Jozafina, et al.
Publicado: (2022) -
Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach
por: Benguigui, Madeleine, et al.
Publicado: (2017) -
The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment
por: Vorontsova, Avital, et al.
Publicado: (2020) -
Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells
por: Benguigui, Madeleine, et al.
Publicado: (2019)